Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: Irish PM's Concern As EU Controls Jabs Into Northern Ireland

Fri, 29th Jan 2021 20:39

(Alliance News) - Ireland's Premier Micheal Martin has spoken to the European Commission's president to express concerns over EU plans to block the supply of Covid-19 vaccinations into Northern Ireland.

In an unexpected move on Friday, the EU triggered Article 16 of the Northern Ireland Protocol on Brexit, in a bid to prevent Northern Ireland from being used as a back door to funnel coronavirus vaccine from the bloc into the rest of the UK.

It comes amid the ongoing row between the EU and vaccine supplier AstraZeneca PLC over the number of vaccines made available to the bloc.

Taoiseach Martin spoke to European Commission President Ursula von der Leyen on Friday evening to discuss the matter.

A government spokesperson said: "We are aware of the issue and the Taoiseach is currently in discussions with European Commission president Ursula von der Leyen to express our concerns."

Ireland's Foreign Affairs Minister Simon Coveney tweeted: "We are working with the EU Commission to try to resolve this issue and protect the integrity and operation of the NI Protocol."

Stormont First Minister Arlene Foster branded the EU's triggering of Article 16 an "incredible act of hostility".

Foster spoke to Prime Minister Boris Johnson and Cabinet Office Minister Michael Gove about the issue on Friday evening, and called for a "robust response" from the UK government.

The protocol, which is part of the Brexit withdrawal deal, normally allows for free movement of goods from the EU into Northern Ireland.

Under the terms of the protocol, goods should be able to move freely between the EU and Northern Ireland as the region remains in the single market for goods and still operates under EU customs rules.

The EU has triggered Article 16 of the protocol to temporarily place export controls on this movement in respect of vaccines.

It comes amid a deepening row over the allocation of the Oxford/AstraZeneca vaccine after the company announced delays to its EU operations.

The move to activate Article 16 will frustrate any effort to use Northern Ireland as a back door to bring vaccines into Great Britain.

Foster said: "By triggering Article 16 in this manner, the EU has once again shown it is prepared to use Northern Ireland when it suits their interests but in the most despicable manner – over the provision of a vaccine which is designed to save lives.

"At the first opportunity, the EU has placed a hard border between Northern Ireland and the Republic of Ireland over the supply chain of the coronavirus vaccine."

The regulation means Northern Ireland will be considered an export territory for the purposes of vaccine sent from the EU/the Republic of Ireland.

Northern Ireland's vaccines arrive from the rest of the UK at present so those will be unaffected.

DUP leader Foster added: "With the EU using Article 16 in such an aggressive and most shameful way, it is now time for our government to step up.

"I will be urging the prime minister to act and use robust measures including Article 16 to advance the interests of Northern Ireland and the rest of the UK."

The DUP has previously pressed the British government to invoke the Article 16 mechanism because of disruption to the movement of goods between Britain and Northern Ireland.

SDLP leader Colum Eastwood said the move undermines progress made to defend the interests of the island.

He said: "The disproportionate decision to invoke Article 16 of the Ireland Protocol by the European Commission is a grave error in judgment that undermines the work that has taken place over the last five years to defend the interests of people on this island.

"We face a common threat. Our response to this virus, and to the supply of vaccines, should be characterised by our common values."

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.